CXCL10 and COVID-19: As expected, plasma concentrations of several inflammatory mediators, including IL-1α, IL-6, IL-18, IP-10, HGF, MCP-3, and M-CSF, were elevated in patients with acute COVID-19, especially those with severe disease (Figure 3B).